|
Aug 5
|
3 European Companies That Could Be Trading Below Their Estimated Value
|
|
Aug 5
|
Global Stocks Priced Below Estimated Intrinsic Value
|
|
Aug 5
|
3 European Stocks Estimated To Be Up To 35.6% Below Intrinsic Value
|
|
Aug 1
|
European Stocks That Might Be Trading Below Estimated Fair Value
|
|
Aug 1
|
3 European Stocks That Could Be Undervalued By Up To 49.4%
|
|
Jul 1
|
Camurus' Oczyesa® receives marketing authorization for treatment of acromegaly in the EU
|
|
Jun 10
|
Eli Lilly Bets $870 Million on Extended-Release Obesity Drugs
|
|
Feb 14
|
Camurus AB (FRA:7CA) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Expansion
|